Literature DB >> 932030

Activities of thyroid hormones and related compounds in an in vitro thymocyte assay.

I D Goldfine, G J Smith, C G Simons, S H Ingbar, E C Jorgensen.   

Abstract

Prior studies have demonstrated that the thyroid hormones L-triiodothyronine and L-thyroxine stimulate the rapid uptake of 1-amino-cyclopentane-1-carboxylic acid into isolated rat thymocytes. In the present study the effects of several groups of thyroid hormones and structurally related compounds were investigated to determine the structure-function relations required for stimulation of this membrane process. Particular attention was given to (a) analogues with modifications at the oxygen bridge, the phenolic hydroxyl group, and the group at the 3' position of the outer ring, and (b) the steric orientation of the thyroid hormones. The following were found to be important for maximal activity: (a) the L-isomer configuration, (b) the presence of a 4'-hydroxyl group, (c) the presence of one substituent in both the inner and outer rings (3 and 3' positions), (d) the distal orientation of the 3' substituent in the outer ring of L-triiodothyronine, and (e) the lipophilic character of the 3' substituent. Of lesser importance was the presence of halogen atoms, or an oxygen atom in the ether position. Since these structure-function relations seen in thymocytes parallel in many respects those relations seen in whole-animal studies, it is believed that thymocytes will be a useful tool for further studies of thyroid hormones and their analogues.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932030

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Nuclear receptors for thyroid hormone.

Authors:  L J DeGroot; S Refetoff; J Bernal; P A Rue; A H Coleoni
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine.

Authors:  J Etzkorn; P Hopkins; J Gray; J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

3.  Plasma membrane transport of thyroid hormone: its possible pathophysiological significance.

Authors:  E P Krenning; R Docter; T J Visser; G Hennemann
Journal:  J Endocrinol Invest       Date:  1983-02       Impact factor: 4.256

4.  Direct and synergistic interactions of 3,5,3'-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes.

Authors:  J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

5.  Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells.

Authors:  H H Samuels; F Stanley; J Casanova
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

6.  In vivo stimulation of sugar uptake in rat thymocytes. An extranuclear action of 3,5,3'-triiodothyronine.

Authors:  J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

7.  Enhancement by glucocorticoid deficiency of the increase in cycloleucine accumulation induced in rat thymocytes by triiodothyronine.

Authors:  J R Etzkorn; P Hopkins; D Gluckin; J Gray; I D Goldfine; S H Ingbar
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

8.  3,3'-Diiodothyronine production, a major pathway of peripheral iodothyronine metabolism in man.

Authors:  L A Gavin; M E Hammond; J N Castle; R R Cavalieri
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

9.  Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes.

Authors:  J Segal; S H Ingbar
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 10.  Peripheral metabolism of hormones: clinical implications.

Authors:  R Hoffenberg
Journal:  J R Soc Med       Date:  1979-06       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.